Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 04, 2022

BUY
$11.05 - $12.72 $27,625 - $31,800
2,500 New
2,500 $2,000
Q1 2022

Apr 14, 2022

SELL
$10.61 - $12.88 $106,100 - $128,800
-10,000 Closed
0 $0
Q4 2020

Jan 21, 2021

BUY
$9.05 - $12.2 $90,500 - $122,000
10,000 New
10,000 $14,000
Q4 2017

Jan 17, 2018

SELL
$12.16 - $14.58 $24,320 - $29,160
-2,000 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$12.07 - $14.87 $24,140 - $29,740
2,000
2,000 $0

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $679M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.